Bio-Techne Corp (TECH)
Fixed asset turnover
Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 1,219,640 | 1,159,060 | 1,136,700 | 1,105,600 | 931,032 |
Property, plant and equipment | US$ in thousands | — | — | 226,200 | 288,798 | 281,741 |
Fixed asset turnover | — | — | 5.03 | 3.83 | 3.30 |
June 30, 2025 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $1,219,640K ÷ $—K
= —
The fixed asset turnover ratio for Bio-Techne Corp demonstrates a consistent upward trend over the analyzed period. As of June 30, 2021, the ratio stood at 3.30, indicating that for each dollar invested in fixed assets, the company generated $3.30 in sales. By June 30, 2022, this ratio increased to 3.83, reflecting improved efficiency in utilizing its fixed assets to generate revenue. The upward trajectory continued into June 30, 2023, with the ratio reaching 5.03, which signifies a substantial enhancement in asset utilization efficiency over the three-year span. Data beyond June 30, 2023, is unavailable, precluding further analysis of subsequent years. Overall, the increasing fixed asset turnover ratio suggests that Bio-Techne Corp has become more effective in leveraging its fixed assets to drive sales during this period, potentially due to operational improvements, asset optimization, or strategic investment decisions.
Peer comparison
Jun 30, 2025